South Carolina Ozempic Stomach Paralysis Lawsuit (2024 Update)

Quick Summary

• If you are in South Carolina and suffering from stomach paralysis after using Ozempic, you may be eligible to join ongoing lawsuits against the drug’s manufacturers.
• This article provides the latest updates on the South Carolina Ozempic stomach paralysis lawsuit, including what the case involves, who qualifies, and how you can seek compensation.
• If you or someone you know has experienced complications from Ozempic, Schmidt & Clark, LLP, is here to help. Known for our expertise in plaintiff representation, our primary goal is to ensure you receive the justice and compensation you deserve.

How S&C Can Help With Your Claim?

S&C can help with your claim by providing expert legal guidance and representation for victims of Ozempic-related stomach paralysis. Our firm offers free, confidential case evaluations for those experiencing adverse effects from Ozempic.

During this evaluation, we’ll help you understand your legal rights and the potential for securing compensation through the legal system. We aim to ensure that you are fully informed and prepared to take the necessary steps toward justice.

Our services include:

• Expert legal guidance and representation
• Specialization in pharmaceutical litigation
• Navigating the complexities of your case
• Understanding the emotional and financial toll of severe gastrointestinal issues
• Helping you seek compensation for your suffering

Ozempic Stomach Paralysis Lawsuit

The Ozempic stomach paralysis lawsuit has gained significant traction. As of June 2024, Judge Karen Marston oversees the litigation. This case could involve over 10,000 personal injury lawsuits, highlighting the widespread impact of Ozempic-related injuries.

In February 2024, an MDL class action lawsuit was initiated, consolidating cases involving:

• Ozempic
• Rybelsus
• Wegovy
• Trulicity
• Mounjaro

The plaintiff’s committee has made progress, filing a status report in May 2024 indicating close agreement on a 13-page Plaintiff Fact Sheet. This document is essential in mass tort litigation, as it standardizes the details of personal injuries, medical history, and other relevant facts from plaintiffs. Understanding these developments is crucial for anyone affected by Ozempic and considering legal action.

What Is Ozempic?

According to Healthline, Ozempic is a diabetes drug used to manage type 2 diabetes and aid in weight loss, and it has been at the center of numerous lawsuits due to its severe side effects [1].

This drug, a GLP-1 receptor agonist, is among the diabetes medications and weight loss drugs that work by mimicking the hormone incretin, which stimulates insulin release in response to meals.

While effective in controlling blood sugar levels, Ozempic has been linked to serious gastrointestinal issues, including:

• stomach paralysis
• nausea
• vomiting
• diarrhea
• constipation

If you are taking Ozempic and experiencing any of these symptoms, it is important to consult with your healthcare provider immediately.

Jaclyn Bjorklund filed the first Ozempic lawsuit in Louisiana after she suffered severe gastrointestinal medical issues due to taking Ozempic. The named defendants in this initial lawsuit are Novo Nordisk and Eli Lilly and Company, highlighting the pharmaceutical giants’ role in the ongoing litigation.

These lawsuits argue that the manufacturers failed to provide adequate warnings about the potential for developing gastroparesis, a condition characterized by delayed gastric emptying.

Was Ozempic Recalled?

Ozempic was not recalled despite the severe side effects and numerous lawsuits. However, the FDA is investigating counterfeit Ozempic products in the U.S. drug supply chain, which have been linked to adverse events such as nausea and vomiting.

According to the FDA, these counterfeit products pose a significant risk, including the use of fake needles that increase the chance of infection [2].

The FDA advises consumers to obtain Ozempic only through state-licensed pharmacies and to be vigilant for signs of counterfeiting. While no official recall has been issued, the ongoing lawsuits claim that the manufacturers provided inadequate warnings about the risk of severe gastrointestinal issues, including gastroparesis.

Understanding these nuances is vital for those considering an Ozempic stomach paralysis claim, especially when a healthcare professional decides to prescribe Ozempic.

Side Effects of Ozempic

Ozempic, while effective in managing type 2 diabetes, has been linked to several severe side effects. Researchers have found that the incidence of gastroparesis, a condition involving delayed stomach emptying, increased significantly six months after starting GLP-1 treatment like Ozempic.

Studies from the Mayo Clinic and the University of Kansas also show a higher likelihood of developing gastroparesis among those taking GLP-1 drugs compared to those who are not.

According to Healthline, some other potential side effects of Ozempic include [3]:

• Nausea
• Vomiting
• Diarrhea
• Severe abdominal pain
• Headache
• Dizziness
• Fatigue

If you experience any of these side effects while taking Ozempic, it is important to consult with healthcare providers, like your primary care physician.

New research links weight loss medications like Ozempic and Wegovy to a greater risk of pancreatitis, gastroparesis, and bowel obstruction – Mohit Sodhi, MSc, Research at The Faculty of Medicine, University of British Columbia, Canada

Who Should Not Use Ozempic?

Individuals who have a personal or family history of medullary thyroid carcinoma (MTC), those with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and individuals allergic to semaglutide or any of the medication’s ingredients should not use Ozempic.

People with a history of pancreatitis or type 1 diabetes are also advised against using Ozempic; importantly, the safety and effectiveness of Ozempic in children under 18 years of age have not been established, so it should not be prescribed to this age group.

Understanding these exclusions is essential for anyone considering or currently taking Ozempic. Gastroparesis, a condition causing stomach paralysis, results from weaker and slower stomach muscle contractions needed for digestion.

This can lead to stomach pain and is often a complication of diabetes or surgery. Medications like opioids, some antidepressants, and high blood pressure drugs can also cause gastroparesis.

Damage to the vagus nerve, which controls stomach muscles, is a significant cause of gastroparesis. This condition is more common in women than men and can severely impact the quality of life. Recognizing these symptoms can help potential plaintiffs seek appropriate legal and medical assistance.

How Do You Qualify for an Ozempic Stomach Paralysis Lawsuit?

To qualify for an Ozempic stomach paralysis lawsuit, you must establish a causal link between the use of Ozempic and the development of gastroparesis or related gastrointestinal issues.

The main claim in these lawsuits is that Novo Nordisk failed to provide adequate warnings about the risk of developing gastroparesis as a side effect of the drug.

Individuals who were prescribed Ozempic and experienced serious gastrointestinal troubles leading to hospitalization or were diagnosed with gastroparesis can bring an Ozempic stomach paralysis claim. Establishing this link typically involves gathering medical records and other evidence to support your case.

The Status Of The Ozempic Lawsuit Litigation in South Carolina

The status of Ozempic lawsuit litigation in South Carolina is evolving as part of the broader multidistrict litigation (MDL) process. The MDL aims to consolidate all federal cases into one central jurisdiction for discovery purposes, ensuring consistent court rulings and streamlining the legal process. As of April 2024, the MDL for Ozempic contains 87 pending cases.

Judge Karen Marston oversees this litigation, which could encompass over 10,000 personal injury lawsuits. The goal is to handle the hundreds or thousands of cases expected to join the litigation efficiently. This consolidation creates pressure on defendants to resolve many cases at once, potentially leading to quicker settlements.

The first status conference with Judge Marston was scheduled for March 14, 2024, marking a significant step in managing the Ozempic cases. Understanding the role of MDL in this litigation is crucial for potential plaintiffs in South Carolina, as it impacts the legal strategy and potential outcomes.

Recent Developments in Ozempic Lawsuits

Recent developments in Ozempic lawsuits include the initiation of an Ozempic class action lawsuit in February 2024, which consolidated cases involving Ozempic and similar drugs. As of June 2024, there are 101 pending cases in the Ozempic MDL.

The progress of the cases has been slower than initially anticipated. U.S. District Judge Karen Marston in Philadelphia is managing this litigation, which is expected to encompass over 10,000 personal injury lawsuits.

In May 2024, both sides of the litigation agreed on a 13-page Plaintiff Fact Sheet and authorization form for all plaintiffs. This document is crucial in standardizing the details of personal injuries, medical history, and other relevant facts from plaintiffs. Additionally, a ‘Science Day’ is scheduled for June 14, 2024, to provide an overview of the medical and scientific issues relevant to the Ozempic cases.

These developments indicate significant progress in the litigation process, emphasizing the importance of staying informed and prepared if you’re considering joining the lawsuits. Understanding these updates can help potential plaintiffs navigate their legal options effectively.

Ozempic Lawsuit Settlement Amounts in South Carolina

Ozempic lawsuit settlements in South Carolina could cover various types of damages, including healthcare costs, lost wages, and compensation for pain and suffering.

Plaintiffs may seek compensation for both economic and non-economic losses, such as medical bills, lost income, and the emotional toll of dealing with severe gastrointestinal issues.

The estimated settlement value for top-tier Ozempic cases ranges from $400,000 to $700,000. These amounts reflect the severity of the injuries and the impact on the plaintiff’s life. In some cases, punitive damages may also be sought, especially if the manufacturer’s negligence is proven.

If you have been diagnosed with Ozempic-induced gastroparesis and subsequent stomach paralysis, you may be entitled to financial recovery for your injuries and related losses. It’s important to seek legal advice to understand your options.

Filing an Ozempic Stomach Paralysis Lawsuit in South Carolina

Filing an Ozempic stomach paralysis lawsuit in South Carolina involves establishing a causal link between Ozempic and the complications, consulting your doctor, and seeking legal assistance. Gather medical records and evidence, file within the statute of limitations, and negotiate a settlement. If a settlement fails, proceed to a court trial.

Legal Strategies and Challenges

Legal strategies for Ozempic stomach paralysis lawsuits often focus on claims of “failure to warn,” alleging that Novo Nordisk did not sufficiently inform users about the risk of developing gastroparesis.

Plaintiffs argue that the drug labels do not adequately warn of potential severe injuries despite ongoing use and reported adverse effects. This failure to warn forms the core of many legal arguments against pharmaceutical companies.

A significant challenge in these lawsuits is establishing causation. Plaintiffs must prove that Ozempic directly caused their gastroparesis.

This can be complex, but many physicians support a differential diagnosis method, which evaluates all potential causes and excludes the unlikely ones to isolate the drug as a likely contributor. This method is instrumental in overcoming the legal hurdles associated with proving causation.

Types of Evidence To Present

Building a strong case in an Ozempic lawsuit requires robust evidence. Plaintiffs often need to provide a plaintiff fact sheet detailing individual injuries, medical history, and relevant facts. This helps standardize the discovery process and ensures that all critical data is collected consistently.

Types of Evidence to Present:

• Plaintiff Fact Sheet: Detailing individual injuries, medical history, and relevant facts.
• Medical Records: Documenting the use of Ozempic and the occurrence of gastroparesis or other injuries.
• Clinical Studies and Medical Literature: Linking Ozempic to gastroparesis to support the claim.
• Quick Proof of Drug Use and Injury: Essential to strengthen the case.

This comprehensive evidence collection is vital for a successful lawsuit.

What Is the Statute of Limitations for an Ozempic Lawsuit In South Carolina?

The statute of limitations for an Ozempic lawsuit in South Carolina is three years. This means you have three years from the date you discovered or reasonably should have discovered the injury to file a lawsuit.

It’s crucial to act promptly, as missing this deadline can result in your case being dismissed, leaving you without legal recourse.

Related Articles:

• Louisiana Ozempic Stomach Paralysis Lawsuit
• Illinois Ozempic Stomach Paralysis Lawsuit
• Arkansas Ozempic Stomach Paralysis Lawsuit

See all related dangerous drug lawsuits our attorneys covered so far.

Get Your Free Consultation From Our South Carolina Ozempic Lawyers

The Schmidt & Clark, LLP law firm stands ready to assist you during these difficult times. If you or a loved one has experienced complications from diabetes drugs like Ozempic, reach out to us without delay.

Our team has a wealth of experience in managing such cases and will guide you through the legal process. We will clarify your rights and determine your eligibility for a lawsuit related to these complications.

Take advantage of our free case evaluation, and remember, you only pay fees if we win your case. You can trust that our dedication to your case is unwavering, as though you were a member of our own family. Contact us today for a thorough review of your concerns.

Reference:

1. https://www.healthline.com/health/drugs/ozempic
2. https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-consumers-not-use-counterfeit-ozempic
3. https://www.healthline.com/health/drugs/ozempic-side-effects